Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy
Top Cited Papers
- 1 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (4) , 903-918
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 1: Drug Products Administered by InjectionJournal of Pharmaceutical Sciences, 2013
- Asparagine Deamidation Dependence on Buffer Type, pH, and TemperatureJournal of Pharmaceutical Sciences, 2013
- Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chainJournal of Pharmaceutical Sciences, 2009
- Identification of a Single Tryptophan Residue as Critical for Binding Activity in a Humanized Monoclonal Antibody against Respiratory Syncytial VirusAnalytical Chemistry, 2007
- Evaluation of Hydroperoxides in Common Pharmaceutical ExcipientsJournal of Pharmaceutical Sciences, 2007
- Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerizationJournal of Pharmaceutical Sciences, 2006
- Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathwayImmunology Letters, 2006
- Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1–10, 1–16 fragments of human and mouse β-amyloid peptideJournal of Inorganic Biochemistry, 2004
- The antibody-catalyzed water oxidation pathway – a new chemical arm to immune defense?Trends in Biochemical Sciences, 2004
- Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequencesFree Radical Biology and Medicine, 1990